| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc. | Chief Legal & Admin. Officer | Series A Common Stock | 234,959 | $1,376,859 | $5.86 | 19 Feb 2026 | Direct |
| Sagimet Biosciences Inc. | Chief Legal & Admin. Officer | Stock Option (Right to Buy) | 88,000 | 19 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | 19 Feb 2026 | 2 | $0 | 4 | Chief Legal & Admin. Officer | 20 Feb 2026, 16:43 |
| SGMT | Sagimet Biosciences Inc. | 10 Feb 2026 | 1 | -$14,054 | 4 | Chief Legal & Admin. Officer | 12 Feb 2026, 16:05 |
| SGMT | Sagimet Biosciences Inc. | 04 Nov 2025 | 2 | $0 | 4 | Chief Legal & Admin. Officer | 06 Nov 2025, 16:43 |
| SGMT | Sagimet Biosciences Inc. | 21 Jul 2025 | 1 | -$98,471 | 4 | General Counsel and CCO | 23 Jul 2025, 16:14 |
| SGMT | Sagimet Biosciences Inc. | 06 Feb 2025 | 2 | $0 | 4 | General Counsel and CCO | 07 Feb 2025, 16:42 |
| SGMT | Sagimet Biosciences Inc. | 19 Jul 2024 | 1 | -$33,830 | 4 | General Counsel and CCO | 23 Jul 2024, 16:05 |
| SGMT | Sagimet Biosciences Inc. | 17 Nov 2023 | 1 | $0 | 4 | General Counsel and CCO | 21 Nov 2023, 16:25 |
| SGMT | Sagimet Biosciences Inc. | 18 Jul 2023 | 2 | $0 | 4 | General Counsel and CCO | 20 Jul 2023, 16:19 |
| SGMT | Sagimet Biosciences Inc. | 13 Jul 2023 | 0 | $0 | 3 | General Counsel and CCO | 13 Jul 2023, 21:08 |